Cargando…
Strong Impact of TGF-β1 Gene Polymorphisms on Breast Cancer Risk in Indian Women: A Case-Control and Population-Based Study
INTRODUCTION: TGF-β1 is a multi-functional cytokine that plays an important role in breast carcinogenesis. Critical role of TGF-β1 signaling in breast cancer progression is well documented. Some TGF-β1 polymorphisms influence its expression; however, their impact on breast cancer risk is not clear....
Autores principales: | Pooja, Singh, Francis, Amirtharaj, Rajender, Singh, Tamang, Rakesh, Rajkumar, Raja, Saini, Karan Singh, Megu, Kaling, Goel, Madhu Mati, Surekha, Daminani, Rao, Digumarthi Raghunatha, Rao, Lakshmi, Ramachandra, Lingadakai, Kumar, Sandeep, Kumar, Surender, Vishnupriya, Satti, Satyamoorthy, Kapaettu, Negi, Mahendra Pal Singh, Thangaraj, Kumarasamy, Konwar, Rituraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798290/ https://www.ncbi.nlm.nih.gov/pubmed/24146803 http://dx.doi.org/10.1371/journal.pone.0075979 |
Ejemplares similares
-
MTHFR 677C>T Polymorphism and the Risk of Breast Cancer: Evidence from an Original Study and Pooled Data for 28031 Cases and 31880 Controls
por: Pooja, Singh, et al.
Publicado: (2015) -
Association of CYP19 polymorphisms with breast cancer risk: A case-control study
por: Surekha, Damineni, et al.
Publicado: (2014) -
CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast
por: Rathore, Ankita Singh, et al.
Publicado: (2014) -
Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways
por: Saxena, Ruchi, et al.
Publicado: (2013) -
Severe acute respiratory syndrome coronaviruses contributing to mitochondrial dysfunction: Implications for post-COVID complications
por: Prasada Kabekkodu, Shama, et al.
Publicado: (2023)